Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer [Phase 2]
Phase 2 trial of Disitamab Vedotin for HER2-expressing locally advanced or metastatic castration-resistant prostate cancer is currently recr…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer [NA]
Update on the MENCORE-2 trial evaluating audio recordings to support decision-making in advanced/metastatic prostate cancer.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial of Lu-177 Ludotadipep for metastatic castration-resistant prostate cancer, with ongoing recrui…
-
CLINICAL_TRIALS research · 2023-07-14Clinical Trial Update: ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for ESK981 in metastatic castration-resistant prostate cancer shows completed status with posted results.
-
CLINICAL_TRIALS research · 2022-09-29Clinical Trial Update: A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer [Phase 2]
Phase 2 biomarker study evaluating standard-of-care Radium-223 chloride in metastatic castration-resistant prostate cancer; study completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-12-11Clinical Trial Update: CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating CYT107 following Provenge treatment in metastatic castration-resistant prostate cancer; results pos…
-
CLINICAL_TRIALS research · 2018-02-28Clinical Trial Update: Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO) [NA]
Phase II randomized study evaluating SBRT with Abiraterone acetate versus Abiraterone acetate alone in oligometastatic metastatic castration…
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
This clinical trial update notes that plasma and urine samples were collected from patients with hormone-refractory prostate cancer enrolled…
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC [Phase 1, Phase 2]
ClinicalTrials.gov update describes a Phase 1/2 study evaluating autologous immune cell therapy in combination with a luteinizing hormone-re…
-
CLINICAL_TRIALS research · 2015-06-25Clinical Trial Update: Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate Cancer [NA]
Sponsored by Institut Paoli-Calmettes, this trial analyzed how Heat Shock Protein 27 contributes to the evolution of prostate cancer to an a…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
The Janssen Research & Development trial to assess treatment patterns in metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS research · 2014-08-05Clinical Trial Update: Molecular Phenotype Changes and Personalized Treatment for CRPC [NA]
This clinical trial update discusses molecular phenotype changes and personalized treatment strategies for castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2012-05-04Clinical Trial Update: Radiotherapy vs Observation for CRPC
This document provides an update on a trial comparing radiotherapy versus observation for castration-resistant prostate cancer. The current …
-
CLINICAL_TRIALS research · 2011-12-08Clinical Trial Update: The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer [Phase 2]
Phase 2 clinical trial update examining whether adding androgen deprivation therapy to docetaxel and prednisolone chemotherapy improves outc…
-
CLINICAL_TRIALS research · 2011-02-14Clinical Trial Update: Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients
An observational registry update documenting treatment patterns in castration-resistant prostate cancer; the study sponsored by Sanofi has b…
-
CLINICAL_TRIALS research · 2010-08-18Clinical Trial Update: Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer [Phase 2]
This entry reports on a Phase 2 biomarker study evaluating the combination of sunitinib and docetaxel in castration-resistant prostate cance…
-
CLINICAL_TRIALS research · 2009-07-28Clinical Trial Update: Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
A clinical trial update evaluating whether circulating tumor cells predict survival in hormone-refractory (castration-resistant) prostate ca…
-
CLINICAL_TRIALS research · 2009-03-12Clinical Trial Update: ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere [Phase 2, Phase 3]
This is an update on the ASCENT trial evaluating calcitriol in combination with Taxotere (docetaxel) for prostate cancer, specifically castr…